CNX Therapeutics is a European pharmaceutical company dedicated to improving the lives of patients through the supply of essential medicines.
We commercialise and distribute a portfolio of speciality brands and hospital products in Europe, and through partners, in over 35 countries worldwide.
Our vision is to become a recognised partner of choice through our commercial excellence, patient focus and presence across Europe.
We aim to have a positive impact on society through our pioneering focus on our Environment, Social and Governance (ESG) goals.
CNX Therapeutics commits to align its operations and strategies to the Ten Principles of the United Nations Global Compact
CNX Therapeutics is committed to having a positive impact on society, and we are proud to announce our first key milestone in our mission to take a pioneering approach to ESG; we are now participants to the UN Global Compact, a voluntary leadership platform for the development, implementation and disclosure of responsible business practices.